Nordwand Advisors »

Phio Pharmaceuticals Corp shares owned by Nordwand Advisors

Quarter-by-quarter ownership of Phio Pharmaceuticals Corp (PHIO) shares owned by Nordwand Advisors from 13F filings

Historical chart of Nordwand Advisors investment in Phio Pharmaceuticals Corp

Tip: Access up to 7 years of quarterly data

All positions including Phio Pharmaceuticals Corp held by Nordwand Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phio Pharmaceuticals Corp by Nordwand Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.7k 500 3.45

More positions owned by Nordwand Advisors

Berkshire Hathaway Inc Del Cl A (BRK.A)
Johnson & Johnson (JNJ)
Novocure Ord Shs (NVCR)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded F Income Etf (JPIE)
Grab Holdings Class A Ord (GRAB)
Harbor Etf Trust Internatnal Comp (OSEA)
Ardagh Metal Packaging S A SHS (AMBP)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Mp Materials Corp Com Cl A (MP)
Oaktree Specialty Lending Corp (OCSL)
Series Portfolios Tr Panagram Bbb B (CLOZ)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Nordwand Advisors

Top funds holding Phio Pharmaceuticals Corp

Sabby Management
UBS Group
Tower Research Capital
Nordwand Advisors
Activest Wealth Management
Bank of America Corporation

View all funds holding Phio Pharmaceuticals Corp